These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29307656)

  • 1. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies.
    Hashimoto Y; Hamaguchi M; Tanaka M; Obora A; Kojima T; Fukui M
    Obes Res Clin Pract; 2018; 12(1):4-15. PubMed ID: 29307656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).
    Heianza Y; Arase Y; Tsuji H; Fujihara K; Saito K; Hsieh SD; Tanaka S; Kodama S; Hara S; Sone H
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2952-60. PubMed ID: 24823457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article.
    Lin H; Zhang L; Zheng R; Zheng Y
    Medicine (Baltimore); 2017 Nov; 96(47):e8838. PubMed ID: 29381992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population.
    Wang B; Zhang M; Wang S; Wang C; Wang J; Li L; Zhang L; Ren Y; Han C; Zhao Y; Zhou J; Wang G; Shen Y; Wu D; Pang C; Yin L; Feng T; Zhao J; Luo X; Hu D
    Obes Res Clin Pract; 2018; 12(1):61-71. PubMed ID: 29100915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.
    Jung CH; Kang YM; Jang JE; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Obesity (Silver Spring); 2016 Jun; 24(6):1373-9. PubMed ID: 27112320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults.
    Martinez-Gomez D; Ortega FB; Hamer M; Lopez-Garcia E; Struijk E; Sadarangani KP; Lavie CJ; Rodríguez-Artalejo F
    Mayo Clin Proc; 2019 Nov; 94(11):2209-2219. PubMed ID: 31619366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
    Lonardo A; Mantovani A; Lugari S; Targher G
    Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population.
    Wei Y; Wang J; Han X; Yu C; Wang F; Yuan J; Miao X; Yao P; Wei S; Wang Y; Liang Y; Zhang X; Guo H; Zheng D; Tang Y; Yang H; He M
    Diabetes Metab Res Rev; 2020 Jan; 36(1):e3202. PubMed ID: 31291052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.
    Mirzababaei A; Mozaffari H; Shab-Bidar S; Milajerdi A; Djafarian K
    J Hum Hypertens; 2019 May; 33(5):365-377. PubMed ID: 30568291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
    Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
    Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis.
    Iqbal J; Wu HX; Nawaz MA; Jiang HL; Xu SN; Huang BL; Li L; Cai JM; Zhou HD
    Obes Rev; 2024 Feb; 25(2):e13656. PubMed ID: 37904643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAT-FREE MASS, METABOLICALLY HEALTHY OBESITY, AND TYPE 2 DIABETES IN SEVERELY OBESE ASIAN ADULTS.
    Pramyothin P; Limpattanachart V; Dawilai S; Sarasak R; Sukaruttanawong C; Chaiyasoot K; Keawtanom S; Yamwong P
    Endocr Pract; 2017 Aug; 23(8):915-922. PubMed ID: 28614006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
    Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
    Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children.
    Evia-Viscarra ML; Guardado-Mendoza R
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):215-222. PubMed ID: 31834862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study.
    Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    BMC Endocr Disord; 2020 Jan; 20(1):11. PubMed ID: 31959179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants.
    Zhou Z; Macpherson J; Gray SR; Gill JMR; Welsh P; Celis-Morales C; Sattar N; Pell JP; Ho FK
    Diabetologia; 2021 Sep; 64(9):1963-1972. PubMed ID: 34109441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.